The hardware and bandwidth for this mirror is donated by dogado GmbH, the Webhosting and Full Service-Cloud Provider. Check out our Wordpress Tutorial.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]dogado.de.
BAMP includes a data example.
data(apc)
plot(cases[,1],type="l",ylim=range(cases), ylab="cases", xlab="year", main="cases per age group")
for (i in 2:8)lines(cases[,i], col=i)
For simulating APC data, see vignette(“simulation”, package=“bamp”).
<- bamp(cases, population, age="rw1", period="rw1", cohort="rw1",
model1 periods_per_agegroup = 5)
bamp() automatically performs a check for MCMC convergence using Gelman and Rubin’s convergence diagnostic. We can manually check the convergence again:
checkConvergence(model1)
## [1] TRUE
Now we have a look at the model results. This includes estimates of smoothing parameters and deviance and DIC:
print(model1)
##
## Model:
## age (rw1) - period (rw1) - cohort (rw1) model
## Deviance: 231.17
## pD: 36.75
## DIC: 267.91
##
##
## Hyper parameters: 5% 50% 95%
## age 0.346 0.911 1.921
## period 66.679 204.020 637.133
## cohort 34.832 59.757 96.270
##
##
## Markov Chains convergence checked succesfully using Gelman's R (potential scale reduction factor).
We can plot the main APC effects using point-wise quantiles:
plot(model1)
More quantiles are possible:
plot(model1, quantiles = c(0.025,0.1,0.5,0.9,0.975))
For other models see vignette(“modeling”,package=“bamp”).
Using the prior assumption of a random walk for the period and cohort effect, one can predict cases for upcoming years.
<- predict_apc(object=model1, periods=3) pred
<-max(pred$pr[2,,])
mplot(pred$pr[2,,8],type="l", ylab="probability", xlab="year", ylim=c(0,m))
for (i in 7:1)
lines(pred$pr[2,,i],col=8-i)
legend(1,m,col=8:1,legend=paste("Age group",1:8),lwd=2,cex=0.6)
lines(c(10.5,10.5),c(0,1),lty=2)
More details see vignette(“prediction”,package=“bamp”).
These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.
Health stats visible at Monitor.